Literature DB >> 7557966

Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata.

G M Galbraith1, J P Pandey.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) phenotypes of two polymorphic systems were determined in 50 patients with alopecia areata, a common inflammatory disease of the skin. The distribution of TNF-alpha T1, T2 phenotypes differed between patients with the patchy form of disease and patients with totalis/universalis disease. There was no significant difference in the distribution of TNF-alpha G,A phenotypes between patient groups. The results of this study provide evidence of genetic heterogeneity between the two forms of alopecia areata, and suggest that the TNF-alpha gene or a closely linked locus within the major histocompatibility complex may play a role in the pathogenesis of the patchy form of disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557966     DOI: 10.1007/bf00191802

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  28 in total

Review 1.  Molecular pathology of type 1 diabetes.

Authors:  I L Campbell; L C Harrison
Journal:  Mol Biol Med       Date:  1990-08

2.  Immunologic aspects of hair loss.

Authors:  J C Bystryn; J Tamesis
Journal:  J Invest Dermatol       Date:  1991-05       Impact factor: 8.551

3.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.

Authors:  T Spies; C C Morton; S A Nedospasov; W Fiers; D Pious; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance.

Authors:  M Duvic; M K Hordinsky; V C Fiedler; W R O'Brien; R Young; J D Reveille
Journal:  Arch Dermatol       Date:  1991-01

5.  No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus.

Authors:  F Pociot; A G Wilson; J Nerup; G W Duff
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

6.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

7.  A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha.

Authors:  A G Wilson; C Gordon; F S di Giovine; N de Vries; L B van de Putte; P Emery; G W Duff
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

8.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene.

Authors:  J K Tarlow; F E Clay; M J Cork; A I Blakemore; A J McDonagh; A G Messenger; G W Duff
Journal:  J Invest Dermatol       Date:  1994-09       Impact factor: 8.551

9.  HLA-DP antigens in patients with alopecia areata.

Authors:  N Odum; N Morling; J Georgsen; B K Jakobsen; G Frentz; G F Jensen; L Fugger; A Svejgaard
Journal:  Tissue Antigens       Date:  1990-03

10.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors:  A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  15 in total

1.  Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Wei-Chi Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 2.  [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].

Authors:  P Freyschmidt-Paul; R Happle; R Hoffmann
Journal:  Hautarzt       Date:  2003-08       Impact factor: 0.751

3.  Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.

Authors:  C E Jackson; R E Fischer; A P Hsu; S M Anderson; Y Choi; J Wang; J K Dale; T A Fleisher; L A Middelton; M C Sneller; M J Lenardo; S E Straus; J M Puck
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

4.  A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis.

Authors:  Rajshekhar Alli; Phuong Nguyen; Kelli Boyd; John P Sundberg; Terrence L Geiger
Journal:  J Immunol       Date:  2011-11-23       Impact factor: 5.422

5.  GCF2/LRRFIP1 represses tumor necrosis factor alpha expression.

Authors:  April R Suriano; Amy N Sanford; Nahmah Kim; Miae Oh; Sarah Kennedy; Mark J Henderson; Kelly Dietzmann; Kathleen E Sullivan
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

6.  Polymorphisms for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor necrosis factor alpha -308 promoter: non-association with endometriosis.

Authors:  Yao-Yuan Hsieh; Chi-Chen Chang; Fuu-Jen Tsai; Yuan Hsu; Horng-Der Tsai; Chang-Hai Tsai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

7.  Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma.

Authors:  Ming-Hsui Tsai; Wen-Chi Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

8.  Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever.

Authors:  Giusi Irma Forte; Letizia Scola; Gabriella Misiano; Salvatore Milano; Pasquale Mansueto; Giustina Vitale; Fiamma Bellanca; Maria Sanacore; Loredana Vaccarino; Giovan Battista Rini; Calogero Caruso; Enrico Cillari; Domenico Lio; Serafino Mansueto
Journal:  Clin Vaccine Immunol       Date:  2009-04-22

9.  Lack of association of tumor necrosis factor alpha gene polymorphism in patients with rheumatoid arthritis in central Taiwan.

Authors:  Sui-Foo Lo; Chung-Ming Huang; Mei-Chen Wu; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2003-05-16       Impact factor: 2.631

10.  Association between PTPN22 C1858T polymorphism and alopecia areata risk.

Authors:  Mauricio Salinas-Santander; Celia Sánchez-Domínguez; Cristina Cantú-Salinas; Hugo Gonzalez-Cárdenas; Ana Cecilia Cepeda-Nieto; Ricardo M Cerda-Flores; Rocío Ortiz-López; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2015-09-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.